Myocardial ischemia in patients with dilated cardiomyopathy
暂无分享,去创建一个
[1] D. J. Veldhuisen,et al. Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy , 2009, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.
[2] P. van der Harst,et al. Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[3] W. Fang,et al. Evaluation of left ventricular volumes and ejection fraction by gated SPECT and cardiac MRI in patients with dilated cardiomyopathy , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[4] G. Breithardt,et al. Myocardial Perfusion in Nonischemic Dilated Cardiomyopathy With and Without Atrial Fibrillation , 2009, Journal of Nuclear Medicine.
[5] E. Agapitos,et al. Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. , 2008, Journal of the American College of Cardiology.
[6] D. Jain,et al. Direct imaging of myocardial ischemia: a potential new paradigm in nuclear cardiovascular imaging , 2008, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[7] D. Neglia,et al. Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study , 2008, Journal of cardiovascular medicine.
[8] R. Testa,et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. , 2007, American journal of physiology. Heart and circulatory physiology.
[9] P. Vardas,et al. Acute effect of esmolol intravenously on coronary microcirculation in patients with idiopathic dilated cardiomyopathy. , 2007, The American journal of cardiology.
[10] A. Gavazzi,et al. Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy , 2007, Heart.
[11] H. Gullu,et al. Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy , 2006, Heart.
[12] Barry J Maron,et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.
[13] J. Higaki,et al. Effect of Beta-Blocker Therapy on Myocardial Perfusion Defects in Thallium-201 Scintigraphy in Patients with Dilated Cardiomyopathy , 2005, Cardiology.
[14] H. Demir,et al. Assessment of left ventricular function and volumes for patients with dilated cardiomyopathy using gated myocardial perfusion SPECT and comparison with echocardiography , 2005, Nuclear medicine communications.
[15] D. Neglia,et al. Coronary microvascular dysfunction and idiopathic dilated cardiomyopathy. , 2005, Pharmacological reports : PR.
[16] P. Vardas,et al. Regional coronary flow and contractile reserve in patients with idiopathic dilated cardiomyopathy. , 2004, Journal of the American College of Cardiology.
[17] P. McCarthy,et al. PET abnormalities in patients with nonischemic cardiomyopathy. , 2004, Journal of cardiac failure.
[18] K. Airaksinen,et al. Myocardial perfusion reserve and oxidative metabolism contribute to exercise capacity in patients with dilated cardiomyopathy. , 2004, Journal of cardiac failure.
[19] J. Hatazawa,et al. Myocardial positron emission computed tomographic images obtained with fluorine-18 fluoro-2-deoxyglucose predict the response of idiopathic dilated cardiomyopathy patients to beta-blockers. , 2004, Journal of the American College of Cardiology.
[20] K. Ito,et al. Combined study with FDG PET and Tl SPECT in patients with idiopathic dilated cardiomyopathy , 2003, Nuclear medicine communications.
[21] Diwakar Jain,et al. Direct Imaging of Exercise-Induced Myocardial Ischemia With Fluorine-18–Labeled Deoxyglucose and Tc-99m-Sestamibi in Coronary Artery Disease , 2003, Circulation.
[22] P. Iozzo,et al. Myocardial metabolic and receptor imaging in idiopathic dilated cardiomyopathy , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[23] P. Herrero,et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[24] Gianmario Sambuceti,et al. Myocardial perfusion and coronary microcirculation: From pathophysiology to clinical application , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[25] D. Neglia,et al. Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction , 2002, Circulation.
[26] P Stanko,et al. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] X. Liu,et al. Radionuclide techniques for evaluating dilated cardiomyopathy and ischemic cardiomyopathy. , 2000, Chinese medical journal.
[28] H. Crijns,et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. , 2000, Journal of the American College of Cardiology.
[29] N. Danchin,et al. Radionuclide assessment of regional differences in left ventricular wall motion and myocardial perfusion in idiopathic dilated cardiomyopathy. , 1993, European heart journal.
[30] R. Testa,et al. Myocardial Blood Flow Distribution in Patients With Ischemic Heart Disease or Dilated Cardiomyopathy Undergoing Heart Transplantation , 1993, Circulation.
[31] Y. Doi,et al. Value of dipyridamole thallium-201 imaging in noninvasive differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction. , 1992, The American journal of cardiology.
[32] K. Tsuiki,et al. Segmental wall motion abnormalities in dilated cardiomyopathy: hemodynamic characteristics and comparison with thallium-201 myocardial scintigraphy. , 1987, American heart journal.
[33] W. Roberts,et al. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.
[34] R. Magorien,et al. The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy. , 1983, American heart journal.